Group One Trading
RPRX icon

Group One Trading’s Royalty Pharma RPRX Stock Holding History

Group One Trading’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,093
Closed -$442K – 8580
2025
Q4 		$390K Buy
+10,093
New +$385K ﹤0.01% 3762
2022
Q2 		– Sell
-1,602
Closed -$65.7K – 8427
2022
Q1 		$62K Buy
+1,602
New +$62.9K ﹤0.01% 5937
2021
Q2 		– Sell
-1,438
Closed -$61.2K – 8518
2021
Q1 		$63K Buy
+1,438
New +$68.2K ﹤0.01% 6059

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's RPRX Position: Q1 2026 in Review

Group One Trading sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 10,093 shares — an estimated $442K sold.

Group One Trading first reported a position in RPRX in Q1 2021 and held it in 3 quarters. The position peaked at $390K in Q4 2025. 592 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Group One Trading reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 10,093 Royalty Pharma shares in Q1 2026, an estimated $442K.
  • Group One Trading first reported a position in Royalty Pharma in Q1 2021 and held it in 3 quarters.
  • Group One Trading's Royalty Pharma position peaked at $390K in Q4 2025.
  • 592 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.